4-nitro-2-(3-phenylpropylamino)benzoate has been researched along with cyclopentane in 1 studies
| Studies (4-nitro-2-(3-phenylpropylamino)benzoate) | Trials (4-nitro-2-(3-phenylpropylamino)benzoate) | Recent Studies (post-2010) (4-nitro-2-(3-phenylpropylamino)benzoate) | Studies (cyclopentane) | Trials (cyclopentane) | Recent Studies (post-2010) (cyclopentane) |
|---|---|---|---|---|---|
| 5 | 0 | 1 | 10,498 | 86 | 5,283 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, R; Numata, T; Okada, Y; Sato-Numata, K | 1 |
1 other study(ies) available for 4-nitro-2-(3-phenylpropylamino)benzoate and cyclopentane
| Article | Year |
|---|---|
Distinct pharmacological and molecular properties of the acid-sensitive outwardly rectifying (ASOR) anion channel from those of the volume-sensitive outwardly rectifying (VSOR) anion channel.
Topics: Anions; Arachidonic Acid; Cell Size; Cyclopentanes; HeLa Cells; Humans; Hydrogen-Ion Concentration; Indans; Ion Channels; Ion Transport; Membrane Proteins; Membrane Transport Modulators; Niflumic Acid; Nitrobenzoates | 2016 |